We are live on ! Find out more
FMS icon

Fresenius Medical Care

130 hedge funds and large institutions have $569M invested in Fresenius Medical Care in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

396% more call options, than puts

Call options by funds: $12.3M | Put options by funds: $2.47M

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

0.56% less ownership

Funds ownership: 6.24%5.68% (-0.56%)

12% less funds holding

Funds holding: 147130 (-17)

14% less capital invested

Capital invested by funds: $663M → $569M (-$94.5M)

52% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 29

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
130
Holders Change
-17
Holders Change %
-11.56%
% of All Funds
4.22%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
14
Increased
44
Reduced
44
Closed
29
Calls
$12.3M
Puts
$2.47M
Net Calls
+$9.79M
Net Calls Change
+$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
COPPSERS
26
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.21M
FA
27
FDx Advisors
Illinois
$3.05M -$52.5K -1,612 -2%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$3M +$460K +14,138 +18%
Citigroup
29
Citigroup
New York
$2.91M +$108K +3,310 +4%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$2.84M +$19.6K +602 +0.7%
FWCM
31
Ferguson Wellman Capital Management
Oregon
$2.76M +$2.77M +85,205 New
CS
32
Credit Suisse
Switzerland
$2.73M +$1.61M +49,372 +141%
Morgan Stanley
33
Morgan Stanley
New York
$2.48M -$1.5M -45,994 -38%
BFIM
34
Beese Fulmer Investment Management
Ohio
$2.44M -$41.7K -1,280 -2%
TAM
35
Trillium Asset Management
Massachusetts
$2.4M +$61.8K +1,897 +3%
NFGCM
36
Norman Fields Gottscho Capital Management
New York
$2.28M +$101K +3,115 +5%
Neuberger Berman Group
37
Neuberger Berman Group
New York
$2.22M +$223K +6,851 +11%
Bank of America
38
Bank of America
North Carolina
$2.17M -$30.4K -932 -1%
MAM
39
Martingale Asset Management
Massachusetts
$2.17M
TD Asset Management
40
TD Asset Management
Ontario, Canada
$2.05M +$24.1K +741 +1%
Fifth Third Bancorp
41
Fifth Third Bancorp
Ohio
$1.97M +$225K +6,912 +13%
WAM
42
World Asset Management
Michigan
$1.79M -$311K -9,555 -15%
IG
43
ING Group
Netherlands
$1.7M +$1.71M +52,510 New
HC
44
Highmount Capital
New York
$1.69M -$16.8K -515 -1%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$1.64M +$1.34M +41,217 +432%
Deutsche Bank
46
Deutsche Bank
Germany
$1.56M +$671K +20,620 +74%
GT
47
Glenmede Trust
Pennsylvania
$1.54M -$5.34K -164 -0.3%
PI
48
Putnam Investments
Massachusetts
$1.52M
Comerica Bank
49
Comerica Bank
Texas
$1.51M +$68K +2,089 +5%
BFM
50
Boston Financial Management
Massachusetts
$1.47M -$430K -13,194 -23%

FMS Hedge Fund Activity: Q3 2013 in Review

130 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q3 2013, worth a combined $569M — down 14% from $663M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of FMS and 14 opened new positions — a net loss of 15 holders — while 44 trimmed existing stakes and 44 added.

The largest buyer was Boston Partners, opening a new position worth an estimated $7.15M. The largest seller was Harding Loevner, cutting an estimated $21.2M.

  • 130 institutional investors held Fresenius Medical Care (FMS) as of Q3 2013, down from 147 in Q2 2013.
  • Funds reported $569M of Fresenius Medical Care stock for Q3 2013, down 14% quarter-over-quarter.
  • 14 funds opened new Fresenius Medical Care positions in Q3 2013 and 29 closed out, a net change of -15 holders.
  • The largest Fresenius Medical Care buyer in Q3 2013 was Boston Partners, an estimated $7.15M added.
  • The largest Fresenius Medical Care seller in Q3 2013 was Harding Loevner, an estimated $21.2M sold.

Based on aggregated 13F filings for Q3 2013.